Search results
19 mar 2024 · High levels of serum IL-6 and serum hepcidin and low CD4 cell count were risk factors of anemia of chronic disease in HIV patients on the combination of antiretroviral therapy.
15 maj 2004 · Anemia in human immunodeficiency virus (HIV)–infected patients can have serious implications, which vary from functional and quality-of-life decrements to an association with disease progression and decreased survival.
5 cze 2018 · The pooled crude RR for the association between HIV and incidence of HPV by CD4 count was higher for CD4 level ≤200 cells/μL (pooled RR = 6.65, 95% CI: 2.98 to 14.85; pooled aRR = 5.76, 95% CI: 3.65 to 9.08) than CD4 level >200 cells/μL (pooled RR = 3.20, 95% CI: 2.48 to 4.13; pooled aRR = 3.09, 95% CI: 2.17 to 4.40), but not statistically ...
15 lis 2021 · We found that the pooled prevalence of anemia was 39.7% (95% CI: 31.4%−48.0%) for children living with HIV aged <15 years, 46.6% (95% CI: 41.9%−51.4%) for adults (men and non-pregnant women) living with HIV aged ≥15 years, and 48.6% (95% CI: 41.6%−55.6%) for pregnant women living with HIV.
HPV-related diseases are of major concern for both men and women. Coinfection of HIV and HPV is common and is associated with an increased risk of HPV-related cancers. HPV is the main cause of several cancers, including cervical and anal dysplasias.
12 sty 2024 · Anemia emerges as a significant predictor of accelerated HIV disease progression. Diminished oxygen-carrying capacity compromises cellular and tissue oxygenation, exacerbating the toll on an already compromised immune system.
6 gru 2013 · Anemia is among the most common hematologic abnormalities in patients with HIV and has been associated with disease progression and poor clinical outcomes. 1 Study of the unique pathophysiology of anemia in HIV has been recognized as an important step toward improving therapeutic options and disease management.
